COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues
Bill of Health
JANUARY 12, 2023
Moderna also licensed their mRNA technology from Cellscript LLC – University of Pennsylvania’s successor-in-interest to the 966 patent. government committed more than one billion dollars to Moderna for development of its COVID-19 vaccines. Moderna has since made over $30 billion in COVID-19 vaccine sales.
Let's personalize your content